India Glycols Limited

BSE: 500201 NSE: INDIAGLYCO
India Glycols Limited - chemicals and materials in Udham Singh Nagar, Uttarakhand, India. FY 2026 financials & compliance.
CIN L24111UR1983PLC009097 Incorporated 19 November 1983 ROC Uttarakhand HQ Udham Singh Nagar, Uttarakhand, India
Active Listed - NSE: INDIAGLYCO · BSE: 500201 Public Limited Company chemicals and materials
Data last updated
Market Cap
₹2,223 Cr
INDIAGLYCO · NSE
Share Price
₹325.35
-1.91% today
Revenue
₹4,211 Cr
FY 2025-26 · +11.8% YoY
EBITDA
₹648 Cr
Margin 15.4%
Net Profit
₹292 Cr
FY 2025-26 · +27.2% YoY
P/E (TTM)
7.0x
P/B 0.8x
ROE
11.3%
ROCE 12.2%
Debt / Equity
0.69
Interest cover 33.9x

About India Glycols Limited

Data last updated:

India Glycols Limited is a public limited company based in Udham Singh Nagar, Uttarakhand, India. It operates in the specialty chemicals segment of the chemicals and materials sector. It was incorporated on 19 November 1983 and has been in existence for over 43 years.

Its director Uma Shankar Bhartia and family are #697 among India's richest people (2026).

The company is registered with the Registrar of Companies (ROC), Uttarakhand, under CIN L24111UR1983PLC009097. Its GSTIN is 05AAACI7246P1Z7 (Uttarakhand). The company holds 11 GST registrations, of which 5 are active. It is a listed company as per MCA records. Its shares are listed on BSE: 500201 and NSE: INDIAGLYCO.

The company has an authorised share capital of ₹45 Cr and a paid-up capital of ₹33.51 Cr. It is led by directors including Uma Shankar Bhartia (Managing Director) and Alok Singhal (Whole-Time Director).

Its last annual general meeting (AGM) was held on 19 August 2026, and its latest financial statements are for the year ended 31 March 2026. The registered office is at A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713.

As per the latest consolidated financials for FY 2025-26, the company reported a revenue of ₹4,211.41 Cr, a growth of 11.8% compared to the previous year. For the same year it recorded a net profit of ₹292.25 Cr (net margin 6.9%) and EBITDA of ₹648.43 Cr (EBITDA margin 15.4%). The net worth stands at ₹2,932.78 Cr (up 30% YoY). Total assets are valued at ₹4,694.08 Cr (up 11.8% YoY).

The company has about 1,347 employees on its provident fund (EPFO) records. Its group structure includes 3 subsidiaries and 1 joint venture.

The company is associated with 3 brands: Ennature Biopharma, Principle Circle and India Glycols. As per MCA filings, the company has open charges of ₹3,293.96 Cr and satisfied charges of ₹12,932 Cr on record. Court records list 281 cases involving the company, including 157 filed by the company and 124 filed against it; 51 cases are pending. The company has 45 deals on record (45 market trades); the latest was in October 2024. Its 7 peer companies in the Chemicals industry (Industrial Gases, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 4 larger and 3 smaller; the largest is Godrej Industries Limited with revenue of ₹21,924 Cr. The company has 15 MSME Form 1 returns on record for the period ending Mar 2010, listing 15 overdue payments to 1 micro and small supplier.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indiaglycols.com.

Company details

CIN L24111UR1983PLC009097
Registration Number 009097
Incorporation Date 19 November 1983
ROC Uttarakhand
Listing Status Listed - Listed on NSE (INDIAGLYCO); Listed on BSE (500201)
Company Status Active
Date of Last AGM 19 August 2026
Date of Balance Sheet 31 March 2026
Compliance Status Active Compliant

CIN history

India Glycols has one previous CIN (Corporate Identification Number): L24111UP1983PLC009097. The current CIN is L24111UR1983PLC009097, which is the unique identifier assigned by the Registrar of Companies.

CINStatus
L24111UR1983PLC009097Current
L24111UP1983PLC009097Previous
Key People
Uma Shankar Bhartia Managing Director Alok Singhal Whole-Time Director Pragya Bhartia Barwale Director

Recognitions & Rankings of India Glycols

Contact details

India Glycols Limited's registered office is in Udham Singh Nagar, Uttarakhand. Its website is indiaglycols.com. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Website
    indiaglycols.com
  • Social Media
  • Registered Address
    A – 1 Industrial Area Bazpur Road Kashipur, Udham Singh Nagar, Uttarakhand, India – 244713
  • Industry
    Chemicals and Materials, Specialty Chemicals, Industrial & Specialty Gases

To see the full contact details of India Glycols Limited, buy the company report.

Comprehensive company report
India Glycols Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Brands

India Glycols operates multiple associated brands including Ennature Biopharma, Principle Circle, and India Glycols. Each brand links to its own profile.

BrandDescriptionWebsite
Ennature Biopharma
Manufactures and supplies pure nicotine, pharmaceutical actives, and nutraceutical ingredients globally.ennaturebiopharma.com
Principle Circle
Offers management consulting and innovative products in education and entertainment sectors.principlecircle.com
India Glycols
Bulk, specialty, and performance chemicals are supplied to various industries.indiaglycols.com

Business activity

The main business activities of India Glycols are manufacturing and trade. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products and wholesale trading. 2 activity segments are registered with the MCA.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products
GTradeG1Wholesale Trading

To see the full business activity and turnover split of India Glycols Limited, buy the company report.

Financials of India Glycols Limited

FY 2025-26 filings available

India Glycols Limited reported revenue of ₹4,211.41 Cr (up 11.8% YoY) for FY 2025-26.

Financial Highlights

FY 2025-26 · Consolidated
Revenue
₹4,211 Cr
+11.8% YoY
EBITDA
₹648 Cr
+26.9% YoY
Profit After Tax
₹292 Cr
+27.2% YoY
Net Worth
₹2,933 Cr
+30.0% YoY
Total Assets
₹4,694 Cr
+11.8% YoY
Total Debt
₹1,691 Cr
-10.6% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue4,2113,7683,2942,6512,8682,3172,735
Revenue growth+11.8%+14.4%+24.3%-7.6%+23.8%-15.3%-
EBITDA648511402296(173)268278
EBITDA margin+15.4%+13.6%+12.2%+11.2%-6.0%+11.6%+10.2%
Profit before tax377292223165379143153
Net profit292230179108164153130
Net profit margin+6.9%+6.1%+5.4%+4.1%+5.7%+6.6%+4.8%
EPS (₹)43.6874.5855.8740.40109.7742.5137.03
Balance sheet
Total assets4,6944,1973,4473,1823,0502,6502,361
Net worth2,9332,2562,0511,9011,7971,1691,034
Total debt1,6911,8921,3481,1121,0421,137999
Cash & bank49.8377.4413811310297.5491.71
Net working capital174280173328365215189
Cash flow
Cash from operations769362439326116137343
Cash from investing(767)(736)(503)(330)76.45(148)(151)
Cash from financing22.5435489.91(0.51)(189)10.75(216)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,1309761,1021,0921,040863975961
Revenue growth (YoY)+8.6%+13.1%+13.0%+13.6%+7.4%---
Other income20.9813.604.0013.7320.0212.9719.3015.16
EBITDA170166175158150146124116
EBITDA margin+15.0%+17.1%+15.8%+14.4%+14.4%+16.9%+12.7%+12.0%
Depreciation42.4841.2341.2238.4834.4532.5927.4727.57
Interest25.1826.4146.8149.2844.6844.5344.0739.91
Profit before tax12311290.6183.6190.5381.7971.4263.46
Tax26.0525.5823.0418.5517.2817.7714.6113.75
Net profit96.8386.8867.5765.0673.2564.0256.8149.71
EPS (₹)14.4513.6410.7910.5123.6620.6818.3516.06
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue4,2113,7673,2912,6502,8632,2802,714
Revenue growth+11.8%+14.5%+24.2%-7.4%+25.6%-16.0%-
EBITDA646507398252232258278
EBITDA margin+15.3%+13.5%+12.1%+9.5%+8.1%+11.3%+10.2%
Profit before tax367242202123352143166
Net profit28217914911212384.34128
Net profit margin+6.7%+4.8%+4.5%+4.2%+4.3%+3.7%+4.7%
EPS (₹)42.1258.2649.0031.8992.1827.2341.43
Balance sheet
Total assets4,2993,8123,1122,8682,7122,6532,413
Net worth2,5371,8711,7161,5881,5121,2451,158
Total debt1,6911,8921,3481,1129691,064928
Cash & bank49.0377.1113811310197.1583.88
Net working capital167276173332424286266
Cash flow
Cash from operations769362438326114142344
Cash from investing(767)(736)(503)(330)76.80(157)(156)
Cash from financing22.5435489.93(0.42)(188)15.90(212)
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,1299781,1021,0911,040863975961
Revenue growth (YoY)+8.5%+13.4%+13.1%+13.5%+7.4%---
Other income0.3839.200.742.171.401.595.824.34
Total expenses959814927932893719851845
EBITDA170164176158148144124116
EBITDA margin+15.1%+16.8%+15.9%+14.5%+14.2%+16.7%+12.7%+12.1%
Depreciation42.4841.2341.2238.4834.4532.5927.4627.58
Interest25.1826.4146.8149.2844.6844.5344.0739.91
Profit before tax10313688.3072.4970.1368.1258.4553.20
Tax26.0525.5023.0418.5517.2817.7714.6113.75

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 02 Nov 2026
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,1309761,1021,0921,040863975961
Revenue growth (YoY)+8.6%+13.1%+13.0%+13.6%+7.4%---
Other income20.9813.604.0013.7320.0212.9719.3015.16
EBITDA170166175158150146124116
EBITDA margin+15.0%+17.1%+15.8%+14.4%+14.4%+16.9%+12.7%+12.0%
Depreciation42.4841.2341.2238.4834.4532.5927.4727.57
Interest25.1826.4146.8149.2844.6844.5344.0739.91
Profit before tax12311290.6183.6190.5381.7971.4263.46
Tax26.0525.5823.0418.5517.2817.7714.6113.75
Net profit96.8386.8867.5765.0673.2564.0256.8149.71
EPS (₹)14.4513.6410.7910.5123.6620.6818.3516.06
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue4,2113,7683,2942,6512,8682,3172,735
Revenue growth+11.8%+14.4%+24.3%-7.6%+23.8%-15.3%-
Other income51.3560.9542.3963.4070238.3948.57
Total expenses3,5633,2572,8922,3553,0412,0492,457
Employee cost13312310388.8089.1683.3393.28
EBITDA648511402296(173)268278
EBITDA margin+15.4%+13.6%+12.2%+11.2%-6.0%+11.6%+10.2%
Depreciation15511510193.9680.2980.1277.53
Interest16716412199.9669.6683.3896.90
Profit before tax377292223165379143153
Tax84.4561.4050.3223.9639.4311.2837.87
Net profit292230179108164153130
Net profit margin+6.9%+6.1%+5.4%+4.1%+5.7%+6.6%+4.8%
EPS (₹)43.6874.5855.8740.40109.7742.5137.03
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital33.5130.9630.9630.9635.8630.9630.96
Reserves & surplus2,8992,2252,0201,8701,7611,1381,003
Shareholders' funds (net worth)2,9332,2562,0511,9011,7971,1691,034
Minority interest0.000.000.000.00(19.48)0.000.00
Secured loans1,5291,7331,2461,008884986862
Unsecured loans162159102104158150137
Total debt1,6911,8921,3481,1121,0421,137999
Total liabilities4,6944,1973,4473,1823,0502,6502,361
Assets
Gross block5,3624,4823,7463,1582,7272,5812,594
Net block4,5543,8293,2052,7172,3182,1932,228
Capital work in progress36.7098.3983.55125243126172
Investments38938133531833627.0726.35
Inventories8911,1711,106754693610682
Sundry debtors351365384430399362569
Cash & bank balances49.8377.4413811310297.5491.71
Loans & advances206203316349414259252
Total current assets1,4981,8161,9451,6461,6071,3281,595
Total current liabilities1,3241,5371,7721,3181,2421,1121,406
Net working capital174280173328365215189
Total assets4,6944,1973,4473,1823,0502,6502,361
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.8426.961.977.053.393.6526.96
Net cash from operating activities769362439326116137343
Net cash from investing activities(767)(736)(503)(330)76.45(148)(151)
Net cash from financing activities22.5435489.91(0.51)(189)10.75(216)
Net change in cash25.03(20.12)24.98(5.07)3.66(0.26)(23.32)
Closing cash49.8377.4413811310297.5491.71
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.8%+14.4%+24.3%-7.6%+23.8%-15.3%-
EBITDA growth+26.9%+27.0%+36.2%+270.8%-164.6%-3.7%-
PBT growth+29.0%+30.9%+35.3%-56.5%+165.4%-6.3%-28.4%
Net income growth+27.2%+28.1%+66.6%-34.5%+7.3%+17.6%-
Revenue CAGR (3Y)+16.7%+9.5%+12.4%-1.0%-5.1%-8.6%+3.1%
EBITDA CAGR (3Y)+29.9%-+14.5%+2.0%--6.0%+5.6%
Profitability & leverage
Net income margin+7.0%+6.1%+5.3%+5.3%+11.9%+5.7%+4.2%
Return on capital employed+12.3%+12.0%+10.4%+7.8%+8.1%+9.0%+11.6%
Return on net worth+11.3%+10.7%+8.8%+6.7%+11.1%+12.0%+13.0%
Debt / equity0.690.750.620.580.730.971.00
Long-term debt / equity0.410.430.330.300.350.430.41
Interest cover33.9141.5340.0149.59-27.5044.3848.24
Efficiency & per share
Fixed asset turnover2.002.202.292.262.492.102.07
Inventory turnover9.537.948.529.1810.138.407.85
Debtors turnover27.4324.1319.4516.0217.3611.6711.71
EPS (₹)43.6874.5855.8740.40109.7742.5137.03
Dividend per share (₹)7.5010.008.007.507.506.006.00
Book value per share (₹)437.55728.61662.44614.12578.75377.41333.92
ParticularsJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue1,1299781,1021,0911,040863975961
Revenue growth (YoY)+8.5%+13.4%+13.1%+13.5%+7.4%---
Other income0.3839.200.742.171.401.595.824.34
Total expenses959814927932893719851845
EBITDA170164176158148144124116
EBITDA margin+15.1%+16.8%+15.9%+14.5%+14.2%+16.7%+12.7%+12.1%
Depreciation42.4841.2341.2238.4834.4532.5927.4627.58
Interest25.1826.4146.8149.2844.6844.5344.0739.91
Profit before tax10313688.3072.4970.1368.1258.4553.20
Tax26.0525.5023.0418.5517.2817.7714.6113.75
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue4,2113,7673,2912,6502,8632,2802,714
Revenue growth+11.8%+14.5%+24.2%-7.4%+25.6%-16.0%-
Other income43.5114.5525.7355.7225834.4951.99
Total expenses3,5653,2602,8932,3982,6322,0222,436
Employee cost13112110287.1387.5981.6991.39
EBITDA646507398252232258278
EBITDA margin+15.3%+13.5%+12.1%+9.5%+8.1%+11.3%+10.2%
Depreciation15511510189.6575.9875.8173.20
Interest16716412195.1962.1773.4590.24
Profit before tax367242202123352143166
Tax84.3761.4050.3223.9666.2658.4337.87
Net profit28217914911212384.34128
Net profit margin+6.7%+4.8%+4.5%+4.2%+4.3%+3.7%+4.7%
EPS (₹)42.1258.2649.0031.8992.1827.2341.43
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital33.5130.9630.9630.9630.9630.9630.96
Reserves & surplus2,5041,8401,6851,5571,4811,2141,127
Shareholders' funds (net worth)2,5371,8711,7161,5881,5121,2451,158
Secured loans1,5291,7331,1961,008884986862
Unsecured loans16215915210484.7477.5366.14
Total debt1,6911,8921,3481,1129691,064928
Total liabilities4,2993,8123,1122,8682,7122,6532,413
Assets
Gross block5,3664,4863,7503,1622,6112,4652,477
Net block4,5543,8293,2052,7172,2322,1022,134
Capital work in progress36.7098.3983.55125237119163
Investments0.040.040.031.5728.6228.6128.59
Inventories8881,1691,104753689606679
Sundry debtors353366389436402365574
Cash & bank balances49.0377.1113811310197.1583.88
Loans & advances200200313346451312301
Total current assets1,4901,8121,9441,6481,6441,3791,638
Total current liabilities1,3221,5361,7711,3171,2201,0941,372
Net working capital167276173332424286266
Total assets4,2993,8123,1122,8682,7122,6532,413
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash6.5126.751.816.643.002.7626.53
Net cash from operating activities769362438326114142344
Net cash from investing activities(767)(736)(503)(330)76.80(157)(156)
Net cash from financing activities22.5435489.93(0.42)(188)15.90(212)
Net change in cash24.55(20.24)24.94(4.83)3.640.24(23.77)
Closing cash49.0377.1113811310197.1583.88
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+11.8%+14.5%+24.2%-7.4%+25.6%-16.0%-
EBITDA growth+27.4%+27.4%+58.0%+8.7%-10.0%-7.2%-
PBT growth+51.7%+19.7%+64.7%-65.1%+146.4%-14.1%-27.4%
Net income growth+57.3%+20.5%+33.2%-8.9%+45.3%-34.2%-
Revenue CAGR (3Y)+16.7%+9.6%+13.0%-0.8%-5.2%-9.0%+3.1%
EBITDA CAGR (3Y)+36.9%+29.8%+15.6%-3.2%-18.0%-7.5%+5.5%
Profitability & leverage
Net income margin+6.7%+4.8%+4.6%+3.7%+10.0%+3.7%+4.7%
Return on capital employed+13.2%+11.7%+10.8%+8.4%+7.6%+7.7%+10.6%
Return on net worth+12.8%+10.1%+9.2%+7.2%+8.9%+7.0%+11.5%
Debt / equity0.810.900.740.670.740.830.83
Long-term debt / equity0.480.500.350.300.330.340.33
Interest cover34.0941.9740.6358.7039.9440.4344.15
Efficiency & per share
Fixed asset turnover1.992.192.292.302.602.182.16
Inventory turnover9.557.958.539.2110.198.397.86
Debtors turnover27.3423.9319.1815.8417.2011.4811.50
EPS (₹)42.1258.2649.0031.8992.1827.2341.43
Dividend per share (₹)7.5010.008.007.507.506.006.00
Book value per share (₹)378.57604.31554.33512.77488.27402.12373.94

To see the full year-wise statements and ratios of India Glycols Limited, buy the company report.

Board of directors of India Glycols Limited

India Glycols has 8 current directors and 17 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Uma Shankar Bhartia
Also directs: Pooja Jhaver Beneficiary LLP, Pragya Bhartia Barwale Beneficiary LLP, Jayshree Bhartia Beneficiary LLP and 5 more
Managing Director29 Nov 199629 Years 11 MonthsCurrent
Pragya Bhartia Barwale
Also directs: Pragya Bhartia Barwale Beneficiary LLP, Lund and Blockley Pvt Ltd, Ajay Commercial Co Pvt Ltd and 5 more
Director24 Jun 20206 Years 4 MonthsCurrent
Shukla Wassan
Also directs: Kwality Wall's (India) Limited, Ge Power India Limited
Director01 Apr 20206 Years 7 MonthsCurrent
Jayshree Bhartia
Also directs: Pooja Jhaver Beneficiary LLP, Pragya Bhartia Barwale Beneficiary LLP, Jayshree Bhartia Beneficiary LLP and 5 more
Director28 May 199927 Years 5 MonthsCurrent
Samrat Banerjee
Also directs: Igl Infrastructure Private Limited, KPSB Realtech LLP, Aces Corporate Consultants LLP and 5 more
Director01 Oct 20242 Years 1 MonthsCurrent
Sushil Dutt SalwanDirector01 Oct 20242 Years 1 MonthsCurrent
Showing 6 of 8 current directors. View all directors

Peer comparison

India Glycols Limited is compared with the 7 companies closest to it by revenue in the Chemicals industry (Industrial Gases, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
Godrej Industries Limited₹21,924 Cr (FY 2025)21.0%Mumbai, Maharashtra, India
Pidilite Industries Limited₹13,388 Cr (FY 2025)7.0%Mumbai, Maharashtra, India
Mcpi Private Limited₹10,772 Cr (FY 2025)10.0%Kolkata, West Bengal, India
Dow Chemical International Private Limited₹10,135 Cr (FY 2025)4.0%Thane, Maharashtra, India
Deccan Fine Chemicals (India) Private Limited₹8,738.51 Cr (FY 2024)-1.0%Hyderabad, Telangana, India
Aarti Industries Ltd₹6,381.66 Cr (FY 2024)-4.0%Vapi, Gujarat, India
Himadri Speciality Chemical Limited₹4,664.32 Cr (FY 2025)10.0%Kolkata, West Bengal, India
India Glycols Limitedthis company₹4,211.41 Cr (FY 2026)₹292.25 Cr6.9%11.8%1,347Udham Singh Nagar, Uttarakhand, India

To see the full peer comparison of India Glycols Limited, buy the company report.

Auditor

India Glycols Limited is audited by K N Gutgutia & Co. for the financial year 2023.

Auditor firmFinancial yearFirm registration number
K N Gutgutia & Co.FY 2023304153E

Shareholding

Shareholding for the quarter ended Sep 2026: promoters hold 59.60%, foreign institutional investors hold 2.20%, domestic institutional investors hold 5.20% and retail and other public shareholders hold 33.00%.

Promoters: 59.60%DII (Domestic Institutional): 5.20%FII (Foreign Institutional): 2.20%Retail & Others: 33.00%
Sep 2026
QUARTER
59.60% Promoters
5.20% DII (Domestic Institutional)
2.20% FII (Foreign Institutional)
33.00% Retail & Others
Promoter holding - history
Now 59.60% · Sep 2026High 61.00% · Dec 2025Low 59.60% · Mar 2026
58%59%60%61%62%Dec 2025Mar 2026Jun 2026Sep 2026Dec 2025: 61.00%Mar 2026: 59.60%Jun 2026: 59.60%Sep 2026: 59.60%61.00%59.60%59.60%
Shareholding trend - last 6 quarters
Sep 2026Jun 2026Mar 2026Dec 2025
Promoters59.60%59.60%59.60%61.00%
Public40.40%40.40%40.40%39.00%

Charges & borrowings

Open charges
₹3,293.96 Cr
Satisfied charges
₹12,932 Cr
Breakdown by lending institutions
Sbicap Trustee Company Limited₹2,398.41 Cr
Others₹893.08 Cr
Axis Bank Limited₹2.26 Cr
Hdfc Bank Limited₹0.20 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
09 Sep 2026101399204Others₹108.28 CrOpen
13 May 2026101302973Others₹25 CrOpen
11 Mar 2026101264292Others₹16 LakhOpen
11 Mar 2026101264300Others₹18 LakhOpen
06 Feb 2026101244119Others₹28 LakhOpen

To see the full charge records of India Glycols Limited, buy the company report.

Total charge records: 215 View all charges

Deals & funding

India Glycols Limited has 45 deals on record (45 market trades); the latest was in October 2024.

Total deals
45
Market trades
45

Deals on record (5 of 45)

WhenDealAmountParties
Oct 2024Market trade₹29.41 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Oct 2024Market trade₹28.17 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Jul 2024Market trade₹64.25 CrBuyer: Prrsaar Commodities Pvt Ltd, Qe Securities LLP , Adroit Financial Services Private Limited
Seller: Prrsaar Commodities Pvt Ltd, Qe Securities LLP , Adroit Financial Services Private Limited
Jan 2024Market trade₹17.95 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP
Jan 2024Market trade₹17.67 CrBuyer: Graviton Research Capital LLP
Seller: Graviton Research Capital LLP

To see the full deal history of India Glycols Limited, buy the company report.

Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.

Credit ratings & regulatory alerts

India Glycols Limited was last rated by Care on 12 Dec 2022.

Rating agencyRated onRating
Care12 Dec 2022

To see the full credit ratings and regulatory alerts of India Glycols Limited, buy the company report.

MSME payment delays

India Glycols Limited has 15 MSME Form 1 returns on record for the period ending Mar 2010, listing 15 overdue payments to 1 micro and small supplier. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (1 of 1)

SupplierAmount dueDue sinceReported on
an individual supplier

To see the full MSME payment records of India Glycols Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

Group structure & subsidiaries

India Glycols has 3 subsidiary companies, 1 joint venture, and 1 associated company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.

3
Subsidiary companies
1
Joint ventures
1
Associated companies
Key subsidiaries
Company NameCINShares held
Igl Chemicals and Services Private LimitedU24200UR2021PTC012141
Ennature Bio Pharma Private LimitedU24290UR2021PTC013005
Igl Finance LimitedU65922UR1997PLC022992

To see the full group structure of India Glycols Limited, buy the company report.

Employees & EPFO

India Glycols Limited has a workforce of 1,347 employees on its EPFO records as of Mar 26, 2024, across 5 active EPFO establishments.

Employee count
1,347
Active EPFO establishments
5
Employee growth
4.18%

GST

India Glycols has 11 GST registrations: 5 active and 6 cancelled or inactive. The first 4 active GSTINs are listed below.

Total GSTINs
11
Active
5
Cancelled / inactive
6
GSTINStateStatusRegistered on
05AAACI7246P1Z7UttarakhandActive01 Jul 2017
09AAACI7246P1ZZUttar PradeshActive01 Jul 2017
24AAACI7246P1Z7GujaratActive01 Jul 2017
09AAACI7246P2ZYUttar PradeshActive06 Jul 2017

To see the full GST registrations and return filing status of India Glycols Limited, buy the company report.

Recent activity

India Glycols Limited has 40 board changes on record since 1983: 24 appointments and 16 cessations. The latest: Samrat Banerjee was appointed as Director on 01 Oct 2024.

Charges
A charge with Others amounted to Rs. 108.28 Cr with Charge ID 101399204 was registered on 09 Sep 2026.
AGM
India Glycols Limited last Annual general meeting of members was held on 19 Aug 2026 as per latest MCA records.
Charges
A charge registered on 24 Jun 2022 via Charge ID 100585966 with Sbicap Trustee Company Limited was fully satisfied on 19 May 2026.
Charges
A charge with Sbicap Trustee Company Limited of Rs. 100.00 Cr registered on 18 May 2022 with Charge ID 100580961 was modified on 15 May 2026.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101302973 was registered on 13 May 2026.
Charges
A charge registered on 27 Dec 2023 via Charge ID 100850683 with Tata Cleantech Capital Limited was fully satisfied on 13 May 2026.
Charges
A charge registered on 28 Aug 2024 via Charge ID 100971898 with Others was fully satisfied on 10 Apr 2026.
Charges
A charge registered on 23 Jul 2025 via Charge ID 101134940 with Others was fully satisfied on 04 Apr 2026.
Charges
A charge registered on 19 May 2025 via Charge ID 101103763 with Others was fully satisfied on 01 Apr 2026.
Charges
A charge registered on 07 Mar 2025 via Charge ID 101075691 with Others was fully satisfied on 01 Apr 2026.
Filing
India Glycols Limited has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Uttarakhand.
Charges
A charge with Others amounted to Rs. 0.16 Cr with Charge ID 101264292 was registered on 11 Mar 2026.

509 earlier events are in the company report.

News

Frequently asked questions

India Glycols is an active public limited company based in Udham Singh Nagar, Uttarakhand, India. The company works in specialty chemicals, within the chemicals and materials industry. It was incorporated on 19 November 1983 (43+ years old) and is registered under CIN L24111UR1983PLC009097. Listed on BSE: 500201 and NSE: INDIAGLYCO.

India Glycols reported revenue of ₹4,211.41 Cr for FY 2025-26 (up 11.8% YoY) based on consolidated financials.

India Glycols has 8 current directors:

The latest financial statements of India Glycols on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 19 August 2026. Year-wise statements from 2015 are in the company report.

The GSTIN of India Glycols is 05AAACI7246P1Z7, registered in Uttarakhand. The company has 11 GST registrations in all, of which 5 are active and 6 are cancelled or inactive. Other active GSTINs include 09AAACI7246P1ZZ (Uttar Pradesh), 24AAACI7246P1Z7 (Gujarat), 09AAACI7246P2ZY (Uttar Pradesh).

The CIN (Corporate Identification Number) of India Glycols is L24111UR1983PLC009097. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Yes. India Glycols is a listed company as per MCA records. Its shares are listed on both BSE (code: 500201) and NSE (symbol: INDIAGLYCO).

India Glycols has 281 court cases on record: 157 filed by the company and 124 filed against it. 51 are pending. Most are in the district courts.

India Glycols was incorporated on 19 November 1983, making it 43+ years old. It is registered with the Registrar of Companies, Uttarakhand.

India Glycols has 45 deals on record (45 market trades); the latest was in October 2024.

The peers of India Glycols by revenue are Godrej Industries Limited, Pidilite Industries Limited, Mcpi Private Limited, Dow Chemical International Private Limited, Deccan Fine Chemicals (India) Private Limited and 2 more, all in the Chemicals industry (Industrial Gases, Specialty Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).

Samrat Banerjee was appointed as Director on 01 Oct 2024. Sushil Dutt Salwan was appointed as Director on 01 Oct 2024. Jagmohan Nandlal Kejriwal ceased to be Director on 30 Sep 2024. India Glycols has 40 board changes on record in total.